Chris Mancill
About Chris Mancill
Chris Mancill is the Senior Vice President & Head of U.S. Value, Access & Payment at Bristol Myers Squibb, with over 25 years of experience in market access, government affairs, and advocacy.
Company
Chris Mancill currently serves as the Senior Vice President & Head, U.S. Value, Access & Payment (VA&P) at Bristol Myers Squibb. Based in Princeton, New Jersey, United States, Bristol Myers Squibb is known for its focus on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. In this role, Mancill oversees critical strategies related to market access, pricing, and payment methodologies.
Title
As the Senior Vice President & Head, U.S. Value, Access & Payment (VA&P) at Bristol Myers Squibb, Chris Mancill leads efforts to enhance the company's market access and payment strategies. His responsibilities include ensuring that patients have access to innovative treatments by navigating complex reimbursement landscapes and developing effective pricing strategies.
Education and Expertise
Chris Mancill earned a Master of Arts from the University of Virginia, where he studied from 1993 to 1995. He also holds a Bachelor of Arts from Christopher Newport University, where he completed his studies from 1989 to 1993. Mancill has over 25 years of experience in market access, government affairs, and advocacy, encompassing global, federal, and state levels.
Background
With extensive experience spanning over two and a half decades, Chris Mancill has held significant roles at major organizations such as Amgen, Merck KGaA, and MorphoSys. His career also includes substantial contributions at the American Red Cross, the Healthcare Financial Management Association, and Avalere Health, where he managed a variety of strategic initiatives.
Achievements
Chris Mancill has a proven record of strategic leadership in areas such as public policy, pricing, and market access. Throughout his career, he has been instrumental in shaping successful strategies that address reimbursement issues and advocate for patient access at multiple levels of government and within the healthcare industry.